These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1318680)

  • 1. Pharmacokinetics of temafloxacin in humans after multiple oral doses.
    Granneman GR; Carpentier P; Morrison PJ; Pernet AG
    Antimicrob Agents Chemother; 1992 Feb; 36(2):378-86. PubMed ID: 1318680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of temafloxacin after multiple oral administration.
    Granneman GR
    Clin Pharmacokinet; 1992; 22 Suppl 1():14-23. PubMed ID: 1319867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temafloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Granneman GR; Braeckman R; Kraut J; Shupien S; Craft JC
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2345-51. PubMed ID: 1666497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of temafloxacin in humans after single oral doses.
    Granneman GR; Carpentier P; Morrison PJ; Pernet AG
    Antimicrob Agents Chemother; 1991 Mar; 35(3):436-41. PubMed ID: 2039194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of temafloxacin in patients with liver impairment.
    Granneman GR; Mahr G; Locke C; Nickel P; Kirch W; Fabian W; Kinzig M; Naber KG; Sörgel F
    Clin Pharmacokinet; 1992; 22 Suppl 1():24-32. PubMed ID: 1319868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of age on the pharmacokinetics of temafloxacin.
    Granneman GR; Guay DR
    Am J Med; 1991 Dec; 91(6A):71S-75S. PubMed ID: 1662898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
    Mattina R; Bonfiglio G; Cocuzza CE; Gulisano G; Cesana M; Imbimbo BP
    Chemotherapy; 1991; 37(6):389-97. PubMed ID: 1662127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cimetidine on the pharmacokinetics of temafloxacin.
    Sörgel F; Granneman GR; Stephan U; Locke C
    Clin Pharmacokinet; 1992; 22 Suppl 1():75-82. PubMed ID: 1319874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the pharmacokinetic profile of temafloxacin.
    Dudley MN
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():55-64. PubMed ID: 1664830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of food on the bioavailability of temafloxacin. A review of 3 studies.
    Granneman GR; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():48-56. PubMed ID: 1319871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
    Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and biliary elimination of temafloxacin in pigs.
    Jehl F; Bresler L; Koechlin C; Merle-Melet M; Didelot JP; Hazebroucq J
    J Antimicrob Chemother; 1992 Aug; 30(2):189-96. PubMed ID: 1328135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatobiliary elimination of temafloxacin.
    Sörgel F; Granneman GR; Mahr G; Kujath P; Fabian W; Nickel P
    Clin Pharmacokinet; 1992; 22 Suppl 1():33-42. PubMed ID: 1319869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of temafloxacin into body tissues and fluids.
    Sörgel F
    Clin Pharmacokinet; 1992; 22 Suppl 1():57-63. PubMed ID: 1319872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.
    Nakashima M; Uematsu T; Kosuge K; Umemura K; Hakusui H; Tanaka M
    Antimicrob Agents Chemother; 1995 Jan; 39(1):170-4. PubMed ID: 7695301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects.
    Bron NJ; Dorr MB; Mant TG; Webb CL; Vassos AB
    J Antimicrob Chemother; 1996 Dec; 38(6):1023-9. PubMed ID: 9023649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antacid medication on the pharmacokinetics of temafloxacin.
    Granneman GR; Stephan U; Birner B; Sörgel F; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():83-9. PubMed ID: 1319875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA
    Am J Med; 1992 Apr; 92(4A):18S-21S. PubMed ID: 1316065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.